Hongri Pharmaceutical: Announcement on the Company's Obtaining a Drug Registration Certificate
Hongri Pharmaceutical: 300026 Hongri Pharmaceutical Investor Relations Management Information 20240419
Hongri Pharmaceutical: Announcement on holding the 2023 Online Results Briefing
Hongri Pharmaceutical: Joint Credit Assessment Co., Ltd.'s concern announcement regarding changes in the chairman and general manager of Tianjin Hongri Pharmaceutical Co., Ltd.
Hongri Pharmaceutical: Announcement of Resolutions of the 17th Meeting of the Eighth Board of Directors
Hongri Pharmaceutical: 2023 Supervisory Committee Work Report
Hongri Pharmaceutical: Opinions of Southwest Securities Co., Ltd. on the storage and use of funds raised by Tianjin Hongri Pharmaceutical Co., Ltd. in 2023
Hongri Pharmaceutical: Independent Director\'s Debriefing Report (Li Li)
Hongri Pharmaceutical: 2023 Annual Audit Report
Hongri Pharmaceutical: Special opinion of the board of directors on the independent assessment of sole director
Hongri Pharmaceutical: 2023 Audit Report
Hongri Pharmaceutical: Independent Director's Debriefing Report (Tu Pengfei)
Red Sun Pharmaceutical: Announcement of Supervisory Board Resolutions
Hongri Pharmaceutical: Special Report of the Board of Directors on the Annual Storage and Actual Use of Raised Funds
Hongri Pharmaceutical: Independent Director's Debriefing Report (Wang Shengtian)
Hongri Pharmaceutical: Announcement of Board Resolutions
Hongri Pharmaceutical: Announcement on renewing the 2024 Audit Institution
Hongri Pharmaceutical: Special instructions on the use of non-operating capital and other related capital transactions in 2023
Hongri Pharmaceutical: Verification Report on the Annual Storage and Use of Funds Raised in 2023
Hongri Pharmaceutical: Independent Director's Debriefing Report (Gong Tao)
No Data